Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Shrinking team NBB
FTE fell two years in a row, from 51.4 to 40.4.
Financials
Financial year 2025
NOVELLAS HEALTHCARE from Ternat, company number BE0825892939, closed financial year 2025 with a result of € -208,017 after tax. For that financial year NOVELLAS HEALTHCARE recorded a gross margin of € 4.7 million and equity of € 1.6 million. Compared with financial year 2024, the result moved from € -27,238 to € -208,017. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.
€ 1.6 million
▼ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -208,017
▼ 664 % more loss than in 2024
Profit after tax over the fiscal year.
€ 181,009
▲ € 136,670 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 999,080.
People and assets in 2025
40.4
▼ 6.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 4.3 million
▼ 3% vs 2024
€ 106,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1
▼ € 558 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 464,696
▲ 24% vs 2024
€ 15,103 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 725,411
▲ 2% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 626,840
▼ 10% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 4,982,740 | € 5,664,505 | € 5,076,446 | € 4,679,503 | ▼ 8% |
| Profit after taxes | € 90,123 | € 181,920 | € -27,238 | € -208,017 | ▼ € 180,779 |
| Equity | € 1,660,615 | € 1,842,535 | € 1,815,297 | € 1,607,279 | ▼ 11% |
| Total debts | € 3,409,373 | € 2,922,179 | € 2,444,903 | € 2,475,270 | ▲ 1% |
| Cash | € 427,545 | € 466,288 | € 44,339 | € 181,009 | ▲ € 136,670 |
| Retained profit | € -3,681,307 | € 1,234,335 | € 1,207,097 | € 999,080 | ▼ 17% |
| Dividend | € 350,000 | € 0 | € 0 | € 0 | |
| Bank debt | € 595,091 | € 465,272 | € 376,194 | € 464,696 | ▲ 24% |
| Balance sheet total | € 5,069,988 | € 4,764,713 | € 4,260,200 | € 4,082,549 | ▼ 4% |
| Employees (FTE) | 47 | 51.4 | 46.6 | 40.4 | ▼ 6.2 |
Key figures of NOVELLAS HEALTHCARE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to NOVELLAS HEALTHCARE?
What happened at NOVELLAS HEALTHCARE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 208,017. Source: NBB ↗
- S&M Consult stepped down as director. NBB
- Tom-Torfs Co inspirator stepped down as director. NBB
- Decat Schokkaert stepped down as director. NBB
- S&M Consult became a director. NBB
- Tom-Torfs Co inspirator became a director. NBB
- Decat Schokkaert became a director. NBB
- New establishment in Ternat. KBO
In short
From € 90,123 profit in 2022 to € 208,017 loss in 2025.
Paid € 448,520 in corporate taxes since 2022.
Best year ever: 2023, with € 181,920 profit.
On average € 115,800 of value added per employee in 2025.
A new publication or filing at NOVELLAS HEALTHCARE? We notify you, reason included.
Follow NOVELLAS HEALTHCAREDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of NOVA holding comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
NOVELLAS HEALTHCAREThe shares are held by NOVA holding (99%).
Directors
According to the 2025 annual accounts
Director
since 2021 · until 2026
since 2021 · until 2026
Director
since 2021 · until 2026
Shareholders
99%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Assesteenweg 71 box 1
1740 Ternat
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0825.892.939
- VAT number
- BE 0825.892.939
- Registered office
- Assesteenweg 71 bus 1, 1740 Ternat
- Names & denominations
- NOVELLAS HEALTHCARE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 14 May 2010
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Arbeidsbemiddeling
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering